A View in the Dark: Two Cases of Acute Esophageal Necrosis in the Setting of Diabetic Ketoacidosis.
Lefika BathobakaeRammy BashirDhruv PatelTyler WilkinsonNader MekhealGabriel MelkiYana CavanaghWalid BaddouraPublished in: Journal of investigative medicine high impact case reports (2024)
Acute esophageal necrosis (AEN), also known as Gurvits syndrome, is a rare and potentially life-threatening condition characterized by necrosis of the esophageal mucosa. Acute esophageal necrosis is often associated with critical conditions, such as myocardial infarction, diabetic ketoacidosis (DKA), coronavirus disease 2019 (COVID-19) infection, or post-surgical complications. Patients typically present with nausea, hematemesis, acute dysphagia, and melena. Given its high mortality rate, prompt detection with upper endoscopy and early initiation of treatment are crucial. Most cases of Gurvits syndrome are managed conservatively using intravenous fluids, proton pump inhibitors, and antibiotics. Herein, we present a case series of AEN in the setting of DKA. Both patients received supportive care and were discharged in a stable condition.
Keyphrases
- liver failure
- end stage renal disease
- respiratory failure
- coronavirus disease
- ejection fraction
- newly diagnosed
- drug induced
- chronic kidney disease
- type diabetes
- healthcare
- heart failure
- prognostic factors
- aortic dissection
- peritoneal dialysis
- left ventricular
- low dose
- patient reported outcomes
- cardiovascular disease
- hepatitis b virus
- sars cov
- high dose
- cardiovascular events
- pain management
- chronic pain
- atrial fibrillation
- patient reported
- acute respiratory distress syndrome
- health insurance